Gregor MacRae
Corporate Officer/Principal chez Appledore Wealth Management LLP
Postes actifs de Gregor MacRae
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Appledore Wealth Management LLP | Corporate Officer/Principal | - | - |
Historique de carrière de Gregor MacRae
Anciens postes connus de Gregor MacRae
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | 21/01/2020 | 18/06/2020 |
| OKYO PHARMA LIMITED | Directeur/Membre du Conseil | 19/12/2019 | 10/06/2020 |
Formation de Gregor MacRae
| University of Birmingham | Graduate Degree |
Statistiques
Internationale
| Royaume-Uni | 4 |
| Bermudes | 2 |
Opérationnelle
| Director/Board Member | 2 |
| Graduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OKYO PHARMA LIMITED | Health Technology |
| Entreprise privées | 2 |
|---|---|
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Health Technology |
| Appledore Wealth Management LLP |
- Bourse
- Insiders
- Gregor MacRae
- Expérience
